Illumina ILMN
NASDAQ ILMN
$245.18 +16.25 (+7.10%)
At close: Sep 17, 2026 · 4:00 PM EDT

Illumina (ILMN) Cash from Investing Activities (2009 - 2026)

Illumina's (ILMN) quarterly Cash from Investing Activities came in at -$122.0 million in Q2 2026, down 148.98% on a YoY basis from $249.1 million in Q2 2025, and up 66.67% quarter-over-quarter from -$366.0 million in Q1 2026.

Analysis

Illumina (ILMN) Cash from Investing Activities (2009 - 2026) Analysis & Trends

Illumina (ILMN) has reported Cash from Investing Activities for 18 consecutive years, with -$122.0 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Cash from Investing Activities fell 148.98% year-over-year to -$122.0 million; the trailing twelve-month figure through Jun 2026 stood at -$431.0 million (down 114.43% YoY), and the FY2025 full-year result was -$55.0 million, up 69.1% from the prior year.
  • Cash from Investing Activities advanced to -$122.0 million in Q2 2026 per ILMN's latest filing, from -$366.0 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $478.0 million in Q1 2023 and bottomed at -$366.0 million in Q1 2026.
  • Historically, Cash from Investing Activities has averaged -$34.2 million across 5 years, with a median of -$50.0 million in 2025.
  • The sharpest annual moves came in 2025 and 2026: Cash from Investing Activities soared 325.0% in 2025, then tumbled 480.95% in 2026.
  • Over 5 years, Cash from Investing Activities stood at -$74.0 million in 2022, then slipped by 14.86% to -$85.0 million in 2023, then jumped by 43.53% to -$48.0 million in 2024, then jumped by 325.0% to $108.0 million in 2025, then sank by 212.96% to -$122.0 million in 2026.
  • According to Business Quant data, Cash from Investing Activities over the past three periods registered -$122.0 million, -$366.0 million, and $108.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn 164.00 Mn
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn -10.15 Bn
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn -1.03 Bn
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn -122.00 Mn
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn -3.51 Mn
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn -7.06 Mn
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn -66.70 Mn
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn -2.09 Mn
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn -7.74 Mn
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn -25.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 28, 2026 -122.00 Mn
Mar 29, 2026 -366.00 Mn
Dec 28, 2025 108.00 Mn
Sep 28, 2025 -51.00 Mn
Jun 29, 2025 -49.00 Mn
Mar 30, 2025 -63.00 Mn
Dec 29, 2024 -48.00 Mn
Sep 29, 2024 -41.00 Mn
Jun 30, 2024 -41.00 Mn
Mar 31, 2024 -48.00 Mn
Dec 31, 2023 -85.00 Mn
Oct 1, 2023 -53.00 Mn
Jul 2, 2023 -37.00 Mn
Apr 2, 2023 -56.00 Mn
Jan 1, 2023 478.00 Mn
Apr 3, 2022 -74.00 Mn
Oct 3, 2021 -2.45 Bn
Jul 4, 2021 3.00 Mn
Apr 4, 2021 1.38 Bn
Jan 3, 2021 -34.00 Mn